Russian journal of anaesthesiology and reanimatology 2, 2019 Клинические рекомендации фар


partum hemorrhage management: an Italian multidisciplinary attended pro-



Pdf көрінісі
бет28/31
Дата29.01.2023
өлшемі0,76 Mb.
#166675
1   ...   23   24   25   26   27   28   29   30   31
Байланысты:
Anestesiolog 2019 02 005


partum hemorrhage management: an Italian multidisciplinary attended pro-
tocol. 
Clin Ter
. 2017;168(5):307-316.
98. Ahmadzia H, Phillips J, Katler Q, James A. Tranexamic Acid for Prevention 
and Treatment of Postpartum Hemorrhage: An Update on Management and 
Clinical Outcomes. 
Obstet Gynecol Surv
. 2018;73(10):587-594. 
99. Vogel J, Oladapo O, Dowswell T, Gülmezoglu A. Updated WHO recom-
mendation on intravenous tranexamic acid for the treatment of post-par-
tum haemorrhage. 
Lancet Glob Health
. 2018;6(1):18-19. 
100. Jadon A, Bagai R. Blood transfusion practices in obstetric anaesthesia. 
In-
dian J Anaesth
. 2014;58(5):629-636.
101. Meier J. Blood transfusion and coagulation management. 
Best Pract Res Clin 
Anaesthesiol
. 2016;30(3):371-379.
102. Kaufman R, Djulbegovic B, Gernsheimer T, Kleinman S, et al. AABB. Plate-
let transfusion: a clinical practice guideline from the AABB. 
Ann Intern Med

2015;162(3):205-213.
103. Waters J. Role of the massive transfusion protocol in the management of 
haemorrhagic shock. 
Br J Anaesth
. 2014;113(Suppl 2):3-8.
104. National Blood Authority. 
Patient blood management guidelines: module 5-ob-
stetrics and maternity
. Canberra ACT (Australia): National Blood Authority; 
2015;129.
105. Prevention and Management of Postpartum Haemorrhage: Green-top Guide-
line No. 52. 
BJOG
. 2017;124(5):106-149.
106. Bar-Natan M, Hymes K. Management of Intraoperative Coagulopathy. 
Neu-
rosurg Clin N Am.
2018;29(4):557-565.
107. Butwick A, Goodnough L. Transfusion and coagulation management in ma-
jor obstetric hemorrhage. 
Curr Opin Anaesthesiol
. 2015;28(3):275-284.
108. Kwon J, MacLaren R. Comparison of Fresh-Frozen Plasma, Four-Factor 
Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Fa-
cilitate Procedures in Critically Ill Patients with Coagulopathy from Liver 
Disease: A Retrospective Cohort Study. 
Pharmacotherapy
. 2016;36(10):1047-
1054.
109. Brekelmans M, Ginkel K, Daams J, Hutten B, et al. Benefits and harms of 
4-factor prothrombin complex concentrate for reversal of vitamin K antag-
onist associated bleeding: a systematic review and metaanalysis. 
J Thromb 
Thrombolysis
. 2017;44(1):118-129.
110. Chai-Adisaksopha C, Hillis C, Siegal D, Movilla R, et al. Prothrombin com-
plex concentrates versus fresh frozen plasma for warfarin reversal. A system-
atic review and metaanalysis. 
Thromb Haemost
. 2016;116(5):879-890.
111. Refaai M, Goldstein J, Lee M, Durn B, et al. Increased risk of volume 
overload with plasma compared with four-factor prothrombin com-
plex concentrate for urgent vitamin K antagonist reversal. 
Transfusion

2015;55(11):2722-2729.
112. Goldstein J, Refaai M, Milling TJr, Lewis B, et al. Four-factor prothrombin 
complex concentrate versus plasma for rapid vitamin K antagonist reversal in 
patients needing urgent surgical or invasive interventions: a phase 3b, open-
label, non-inferiority, randomised trial. 
Lancet
. 2015;385(9982):2077-2087.
Клинические рекомендации ФАР 
FAR Clinical Recommendations


26
АНЕСТЕЗИОЛОГИЯ И РЕАНИМАТОЛОГИЯ 2, 2019
113. Johansen M, Wikkelsø A, Lunde J, Wetterslev J, Afshari A. Prothrombin com-
plex concentrate for reversal of vitamin K antagonist treatment in bleeding 
and non-bleeding patients. 


Достарыңызбен бөлісу:
1   ...   23   24   25   26   27   28   29   30   31




©engime.org 2024
әкімшілігінің қараңыз

    Басты бет